|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Pneumonia
|
NIAID
|
1K22AI065425-01A2
|
|
Eicosanoid Production By Infected Lung Epithelial Cells
|
HURLEY, BRYAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$161,304
|
|
Pneumonia
|
NIEHS
|
5F30ES012550-05
|
|
Air Pollution & Respiratory Disease Traineeship
|
HARRIS, AARON
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$51,214
|
|
Pneumonia
|
NHLBI
|
5K08HL081229-03
|
|
Role of IRAK-M in sepsis-induced immunosuppression
|
DENG, JANE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$121,770
|
|
Pneumonia
|
NIDCD
|
5R01DC006452-03
|
|
Effect of the Middle Ear Inflammation On the Inner Ear
|
JUHN, STEVEN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$304,466
|
|
Pneumonia
|
NIDCD
|
5R03DC007511-03
|
|
In Vivo Virulence Gene Expression in Acute Otitis Media
|
LI-KOROTKY, HA-SHENG
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$69,669
|
|
Pneumonia
|
NIAID
|
5R01AI064017-05
|
|
S-Adenosylmethionine and Pneumocystis treatment
|
MERALI, SALIM
|
TEMPLE UNIVERSITY
|
PA
|
$342,524
|
|
Pneumonia
|
NHLBI
|
5K08HL078727-04
|
|
Modulation of Lung Innate Immunity by Prostaglandin E2
|
ARONOFF, DAVID
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$132,300
|
|
Pneumonia
|
NHLBI
|
5R01HL079142-04
|
|
IL-23 / Il-17 and Lung Host Defense
|
KOLLS, JAY
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$379,418
|
|
Pneumonia
|
NHLBI
|
5R01HL077095-04
|
|
Immune response to Pneumocystis in simian model of AIDS
|
NORRIS, KAREN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$580,262
|
|
Pneumonia
|
NIAID
|
5R01AI034937-13
|
|
Genetics of Iron Acquisition by Legionella pneumophila
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY
|
IL
|
$308,537
|
|
Pneumonia
|
NIAID
|
5R01AI043987-10
|
|
Type II Secretion and Legionella pneumophila Infection
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY
|
IL
|
$239,471
|
|
Pneumonia
|
NIAID
|
5R01AI023302-22
|
|
Monoclonal Antibodies for the Study of P. carinii
|
GIGLIOTTI, FRANCIS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$362,764
|
|
Pneumonia
|
NIAID
|
5R01AI066058-02
|
|
Legionella pneumophila developmental cycle & virulence
|
HOFFMAN, PAUL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$370,162
|
|
Pneumonia
|
NHLBI
|
5R01HL077417-03
|
|
Regulation of Pulmonary Host Defense by Leptin
|
MANCUSO, PETER
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$353,359
|
|
Pneumonia
|
NIAID
|
5R01AI048917-07
|
|
Virulence and Immunity to Mucoid P. aeruginosa
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$380,786
|
|
Pneumonia
|
NIAID
|
5R01AI060744-03
|
|
Signal Transduction by Essential VicRKX in Pneumococcus
|
WINKLER, MALCOLM
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$357,474
|
|
Pneumonia
|
NIGMS
|
5R01GM051670-13
|
|
Structural Studies of AIDS-Responsive Drugs
|
CODY, VIVIAN
|
HAUPTMAN-WOODWARD MEDICAL RESEARCH INST
|
NY
|
$382,224
|
|
Pneumonia
|
NIAID
|
5R01AI057575-05
|
|
The Role of TLR4 and RSV F Protein in Immunity to RSV
|
BLANCO, JORGE
|
VIRION SYSTEMS, INC.
|
MD
|
$495,850
|
|
Pneumonia
|
NIAID
|
5R01AI067737-03
|
|
Pneumococcal immunization through a novel mechanism
|
MALLEY, RICHARD
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$402,453
|
|
Pneumonia
|
NIAID
|
5R37AI033713-16
|
|
REGULATION OF PSEUDOMONAS AERUGINOSA PROTEASES
|
IGLEWSKI, BARBARA
|
UNIVERSITY OF ROCHESTER
|
NY
|
$371,495
|
|
Pneumonia
|
NIAID
|
5R01AI059136-05
|
|
SARS Reverse Genetics
|
BARIC, RALPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$271,608
|
|
Pneumonia
|
NIAID
|
5R01AI045459-08
|
|
Variable Gene Use and Pneumococcal Immunity in AIDS
|
PIROFSKI, LIISE-ANNE
|
YESHIVA UNIVERSITY
|
NY
|
$395,309
|
|
Pneumonia
|
NIAID
|
5R03AI068069-02
|
|
Epidemiology and Clinical Features of Human Coronavirus
|
WILLIAMS, JOHN
|
VANDERBILT UNIVERSITY
|
TN
|
$75,292
|
|
Pneumonia
|
NIAID
|
5R01AI031473-11
|
|
Impact of a new group 6 serotype on pneumococcal vaccines
|
NAHM, MOON
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$248,929
|
|
Pneumonia
|
NHLBI
|
5R01HL080621-03
|
|
Macaque Model and Gene Expression Profiling of SARS
|
KATZE, MICHAEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$606,132
|
|
Pneumonia
|
NIAID
|
5R01AI069201-02
|
|
Yeast-Based High-throughput Assays for Proteases of Category A, B, & C Viruses
|
FANG, HONG
|
MICROBIAL NOVOTEQS, INC.
|
TN
|
$404,663
|
|
Pneumonia
|
NIAID
|
5R21AI069276-02
|
|
NKT Cell Recognition of Streptococcus Pneumoniae
|
KRONENBERG, MITCHELL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$224,128
|
|
Pneumonia
|
NIAID
|
5R01AI064481-04
|
|
Gene Expression Patterns and Lifestyles in Legionella
|
SHUMAN, HOWARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$594,505
|
|
Pneumonia
|
NHLBI
|
5R01HL066115-06
|
|
C. pneumoniae and atherosclerotic plaque destabilization
|
ROSENFELD, MICHAEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$373,500
|
|
Pneumonia
|
NIBIB
|
5R01EB000268-07
|
|
Barcoded Nanowires for Multiplexed Clinical Diagnostics
|
KEATING, CHRISTINE
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
PA
|
$274,455
|
|
Pneumonia
|
NIAID
|
5R01AI062259-03
|
|
Aveolar Macrophage Apoptosis and Pneumocystis
|
LEE, CHAO-HUNG
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$359,509
|
|
Pneumonia
|
NIDDK
|
5R01DK068474-03
|
|
Role of Tamm-Horsfall Protein in Urinary Track Infection
|
KUMAR, SATISH
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$285,783
|
|
Pneumonia
|
NIAID
|
5R01AI042075-08
|
|
T cell subsets in murine mycoplasma respiratory disease
|
SIMECKA, JERRY
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$202,894
|
|
Pneumonia
|
NIAID
|
5R01AI064084-04
|
|
Sterol Metabolism in Pneumocystis
|
KANESHIRO, EDNA
|
UNIVERSITY OF CINCINNATI
|
OH
|
$285,561
|
|
Pneumonia
|
NIAID
|
5R21AI065476-02
|
|
Protective Activity of a Multi-Functional Immunogen
|
GOSSELIN, EDMUND
|
ALBANY MEDICAL COLLEGE
|
NY
|
$224,481
|
|
Pneumonia
|
NICHD
|
5K23HD052553-02
|
|
Aspiration Pneumonia in Children with Neurological Impairment
|
SRIVASTAVA, RAJENDU
|
UNIVERSITY OF UTAH
|
UT
|
$137,160
|
|
Pneumonia
|
NHLBI
|
5R01HL087166-02
|
|
Role of TLR Signaling in Ureaplasma-Mediated Neonatal Lung Injury
|
VISCARDI, ROSE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$359,125
|
|
Pneumonia
|
NEI
|
5R01EY016195-02
|
|
Streptococcus pneumoniae ocular pathogenesis and therapy
|
MARQUART, MARY
|
UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
|
MS
|
$329,162
|
|
Pneumonia
|
NHLBI
|
5K24HL086796-02
|
|
Proteomic-based Approach to Ventilator Associated Pneumonia
|
SCHNAPP, LYNN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$155,332
|
|
Pneumonia
|
NIAID
|
5R01AI063520-02
|
|
Immunopathology mediated by RSV-specific CD4 T cells
|
VARGA, STEVEN
|
UNIVERSITY OF IOWA
|
IA
|
$356,502
|
|
Pneumonia
|
NIDCR
|
5K23DE015760-04
|
|
Chlorhexidine and Pneumonia in Nursing Home Residents
|
BINKLEY, CATHERINE
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$128,250
|
|
Pneumonia
|
NIAID
|
5R01AI066013-02
|
|
Mechanisms of Immunity to Pneumococcal Colonization
|
MALLEY, RICHARD
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$414,473
|
|
Pneumonia
|
NIAID
|
5R21AI064444-02
|
|
Archaeal gene recruitment by the Chlamydiales
|
GRAHAM, DAVID
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$182,084
|
|
Pneumonia
|
NIAAA
|
1R01AA016348-01A2
|
|
In Utero Alcohol and Alveolar Macrophage Maturation-A Risk For The Newborn
|
GAUTHIER, THERESA
|
EMORY UNIVERSITY
|
GA
|
$344,682
|
|
Pneumonia
|
NIAID
|
5R01AI029471-17
|
|
Recombinant & live oral Salmonella typhi hybrid vaccines
|
LEVINE, MYRON
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$619,162
|
|
Pneumonia
|
NIAID
|
5R03AI062930-02
|
|
Mycoplasma pneumoniae activation of airway epithelium
|
SIMECKA, JERRY
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$70,632
|
|
Pneumonia
|
NIAID
|
5R01AI054952-04
|
|
Vaccine-enhanced respiratory syncytial virus disease
|
POLACK, FERNANDO
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$343,232
|
|
Pneumonia
|
NHLBI
|
5R01HL083761-03
|
|
Chemokine regulation of immune cell recruitment
|
WRIGHT, TERRY
|
UNIVERSITY OF ROCHESTER
|
NY
|
$378,690
|
|
Pneumonia
|
NCI
|
5R01CA081140-11
|
|
Model for Gene Therapy in X-linked Agammaglobulinemia
|
RAWLINGS, DAVID
|
CHILDREN'S HOSPITAL AND REG MEDICAL CTR
|
WA
|
$297,611
|
|
Pneumonia
|
NIAID
|
5R01AI027913-20
|
|
BIOACTIVITIES OF PNEUMOCOCCAL CELL WALL IN MENINGITIS
|
TUOMANEN, ELAINE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$348,812
|
|
Pneumonia
|
NIAID
|
5U01AI061233-04
|
|
Ultrasensitive Bispecific Antibody Assay for SARS Virus
|
SURESH, MAVANUR
|
UNIVERSITY OF ALBERTA
|
CANADA
|
$177,730
|
|
Pneumonia
|
NIAID
|
5R01AI059597-04
|
|
Alphavirus-based Vaccine for Prevention of MPV Infection
|
CROWE, JAMES
|
VANDERBILT UNIVERSITY
|
TN
|
$383,336
|
|
Pneumonia
|
NIAID
|
1R01AI070693-01A2
|
|
Transcriptional Control of Chlamydial Development
|
BELLAND, ROBERT
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$365,000
|
|
Pneumonia
|
NHLBI
|
5R01HL083436-03
|
|
Gender and Host Defense Against Pneumonia
|
KOBZIK, LESTER
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$398,110
|
|
Pneumonia
|
NIAID
|
1R01AI069116-01A1
|
|
Cyclic AMP Signaling in Pseudomonas aeruginosa Virulence
|
WOLFGANG, MATTHEW
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$329,921
|
|
Pneumonia
|
NIAID
|
5R01AI023549-23
|
|
Genetic Analysis of Monocyte Killing by Bacteria
|
SHUMAN, HOWARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$479,995
|
|
Pneumonia
|
NIAID
|
5R01AI048409-07
|
|
Pheromone Signaling in Pneumocystis Carinii
|
THOMAS, CHARLES
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$274,399
|
|
Pneumonia
|
NIAID
|
5R01AI074283-20
|
|
Cardiotoxicity of Streptococcal Pyrogenic Exotoxins
|
SCHLIEVERT, PATRICK
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$322,294
|
|
Pneumonia
|
NIDCD
|
2R01DC006468-04A1
|
|
RSV Upper Airway Infection and Otitis Media
|
DURBIN, JOAN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$428,678
|
|
Pneumonia
|
NIAID
|
5R01AI068043-02
|
|
Molecular epidemiologic identification of pneumococcal tissue specific genes
|
PETTIGREW, MELINDA
|
YALE UNIVERSITY
|
CT
|
$547,609
|
|
Pneumonia
|
NIAID
|
5R01AI036701-13
|
|
Structure and Expression of Pneumocystis Antigen Genes
|
STRINGER, JAMES
|
UNIVERSITY OF CINCINNATI
|
OH
|
$321,257
|
|
Pneumonia
|
NIAID
|
1K01AI073729-01A1
|
|
Predicting adverse outcomes in children with community-acquired pneumonia
|
SHAH, SAMIR
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$126,792
|
|
Pneumonia
|
NIGMS
|
5R01GM053017-10
|
|
Mechanisms of polysacchairde synthesis by S. pneumoniae
|
YOTHER, JANET
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$304,500
|
|
Pneumonia
|
NIAID
|
5R01AI067888-02
|
|
Recombinant C. trachomatis vaccine
|
DE LA MAZA, LUIS
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$369,886
|
|
Pneumonia
|
NIAID
|
1K24AI073957-01A1
|
|
Neighborhood level determinants of pneumococcal disease transmission
|
METLAY, JOSHUA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$184,893
|
|
Pneumonia
|
NHLBI
|
5R01HL055002-18
|
|
Reconstitution of Immunity to Pneumocystis in SCID Mice
|
HARMSEN, ALLEN
|
MONTANA STATE UNIVERSITY (BOZEMAN)
|
MT
|
$406,539
|
|
Pneumonia
|
NIAID
|
1K08AI071090-01A1
|
|
Mechanisms of intraspecies Competition in Streptococcus pneumoniae.
|
DAWID, SUZANNE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$58,122
|
|
Pneumonia
|
NHLBI
|
5R01HL079395-03
|
|
Staphylococcus aureus Activation of TNF Signaling Pathways
|
PRINCE, ALICE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$385,605
|
|
Pneumonia
|
FIC
|
5R01TW007303-04
|
|
Transmission of Drug-Resistant S. pneumoniae in Brazil
|
PEDREIRA, JOICE
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$51,202
|
|
Pneumonia
|
NHLBI
|
5R01HL084171-03
|
|
SARS Coronavirus Virulence Factors and Lung Pathogenesis
|
WATHELET, MARC
|
UNIVERSITY OF CINCINNATI
|
OH
|
$335,359
|
|
Pneumonia
|
NIAID
|
5R01AI046645-08
|
|
Risk factors for drug resistant pneumococcal bacteremia
|
METLAY, JOSHUA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$644,259
|
|
Pneumonia
|
NHLBI
|
5R01HL048889-09
|
|
Pathogenesis of Aspiration Pneumonitis
|
KNIGHT, PAUL
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$396,250
|
|
Pneumonia
|
NIAID
|
5U01AI061611-04
|
|
Differentiation of Common Respiratory Viruses and SARS
|
PORITZ, MARK
|
IDAHO TECHNOLOGY
|
UT
|
$715,172
|
|
Pneumonia
|
NIGMS
|
5R01GM053439-11
|
|
Enteral vs. IV Feeding: Effect on Mucosal Immunity
|
KUDSK, KENNETH
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$283,500
|
|
Pneumonia
|
NIAID
|
5R01AI049192-08
|
|
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
|
SNAPPER, CLIFFORD
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$324,701
|
|
Pneumonia
|
NIAID
|
1R01AI074986-01A1
|
|
Modeling viral entry and its inhibition using SARS-CoV
|
SIMMONS, GRAHAM
|
BLOOD SYSTEMS RESEARCH INSTITUTE
|
CA
|
$403,250
|
|
Pneumonia
|
NIAID
|
5R01AI062492-04
|
|
Serum Antibodies to Recombinant Pneumocystis Antigens
|
WALZER, PETER
|
UNIVERSITY OF CINCINNATI
|
OH
|
$454,765
|
|
Pneumonia
|
NHLBI
|
5R01HL057243-11
|
|
Role of TLR9 in Lung Antibacterial Host Defense
|
STANDIFORD, THEODORE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$371,680
|
|
Pneumonia
|
NHLBI
|
5R01HL083844-03
|
|
THE ROLE OF PNEUMOCYSTIS IN THE DEVELOPMENT OF COPD
|
CHRISTENSEN, PAUL
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$305,865
|
|
Pneumonia
|
NIAID
|
5R01AI022535-24
|
|
Acquired Immunity and Vaccination for P. aeruginosa
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$341,698
|
|
Pneumonia
|
NHLBI
|
5K23HL075402-04
|
|
Aerosolized xylitol for ventilator-associated pneumonia
|
DURAIRAJ, LAKSHMI
|
UNIVERSITY OF IOWA
|
IA
|
$125,010
|
|
Pneumonia
|
NIAID
|
5R01AI066349-04
|
|
Synergism Between Influenza Virus and Pneumococcus
|
MCCULLERS, JONATHAN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$348,812
|
|
Pneumonia
|
NIAID
|
5R01AI061464-04
|
|
TLR5 and Pulmonary Innate Immunity
|
HAWN, THOMAS
|
UNIVERSITY OF WASHINGTON
|
WA
|
$305,579
|
|
Pneumonia
|
NIAID
|
5R01AI038446-14
|
|
Mechanisms of pneumococcal persistence during carriage
|
WEISER, JEFFREY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$368,577
|
|
Pneumonia
|
NIAID
|
5R01AI019146-24
|
|
Activation of Alginate Genes in Pseudomonas aeruginosa
|
OHMAN, DENNIS
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$323,381
|
|
Pneumonia
|
NHLBI
|
5R01HL080317-05
|
|
Dectin-1 and Immunity Against Pneumocystis Carinii
|
STEELE, CHAD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$303,919
|
|
Pneumonia
|
NIA
|
5F30AG029724-02
|
|
Aging effects on acute lung inflammation after burn injury
|
NOMELLINI, VANESSA
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$26,892
|
|
Pneumonia
|
NIAID
|
5R41AI072847-02
|
|
Scanning Chlamydia proteome for vaccine antigens
|
DE LA MAZA, LUIS
|
IMMPORT THERAPEUTICS, INC.
|
CA
|
$299,255
|
|
Pneumonia
|
NHLBI
|
5R01HL055549-13
|
|
Regulation of TNF receptor signaling and functions
|
RICHES, DAVID
|
NATIONAL JEWISH HEALTH
|
CO
|
$369,790
|
|
Pneumonia
|
NIAID
|
5R01AI070246-02
|
|
Study of Mechanisms Leading to Multidrug-Resistant K. pneumoniae and A. baumannii
|
QUALE, JOHN
|
SUNY DOWNSTATE MEDICAL CENTER
|
NY
|
$267,813
|
|
Pneumonia
|
NHLBI
|
1R43HL091587-01
|
|
A new negative pressure ventilator
|
WHALEN, ROBERT
|
WHALEN BIOMEDICAL, INC
|
MA
|
$103,588
|
|
Pneumonia
|
NIEHS
|
1F30ES016487-01
|
|
Pseudomonas aeruginosa genomic islands and virulence factors
|
KUNG, VANDERLENE
|
NORTHWESTERN UNIVERSITY
|
IL
|
$38,998
|
|
Pneumonia
|
NHLBI
|
1F32HL091642-01
|
|
Role of Surfactant in Mycoplasma Pulmonary Infection and Exacerbation
|
LEDFORD, JULIE
|
DUKE UNIVERSITY
|
NC
|
$46,826
|
|
Pneumonia
|
NINR
|
5R21NR010262-02
|
|
Strategies for Airway Management & Prevention Endotracheal Tube Cuff Intervention
|
SOLE, MARY
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$177,081
|
|
Pneumonia
|
FIC
|
5D43TW007585-03
|
|
Infectious Diseases and Child Health in Pakistan Research Training Program
|
ZAIDI, ANITA
|
AGA KHAN UNIVERSITY
|
PAKIST
|
$141,717
|
|
Pneumonia
|
NIAID
|
5R01AI069509-03
|
|
Pneumococcal conjugate vaccines and old adults
|
NAHM, MOON
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$281,653
|
|
Pneumonia
|
NIAID
|
5R41AI072912-02
|
|
TLR5 Antagonists for Infectious Disease Therapy
|
LORY, STEPHEN
|
MICROBIOTIX, INC
|
MA
|
$300,000
|
|
Pneumonia
|
NIAID
|
1F31AI075538-01A1
|
|
Role of Coronavirus Membrane Protein Carboxy Tail Virus Assembly
|
JONES, ARIEL
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$36,044
|
|
Pneumonia
|
NIAID
|
5K23AI060887-05
|
|
Risk of Infectious Complications in Nosocomial Pneumonia
|
LINKIN, DARREN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$132,462
|
|
Pneumonia
|
NIAID
|
5K02AI060701-06
|
|
Role of RNA Editing by ADAR1 in Infection
|
YANG, JINGHUA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$104,899
|
|
Pneumonia
|
NCI
|
1R01CA132586-01
|
|
Pulmonary inflammation and lung cancer development and progression
|
KARIN, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$322,905
|
|
Pneumonia
|
NHLBI
|
5U10HL080685-04
|
|
Idiopathic Pulmonary Fibrosis Clinical Research Network
|
KING, TALMADGE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$183,907
|
|
Pneumonia
|
NHLBI
|
5U10HL080371-04
|
|
Novel Therapeutic Approaches in IPF
|
MARTINEZ, FERNANDO
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$283,432
|
|
Pneumonia
|
NIAID
|
5R01AI069966-03
|
|
Novel, P. jirovecii Specific Antipneumocystis Agents
|
GANGJEE, ALEEM
|
DUQUESNE UNIVERSITY
|
PA
|
$313,094
|
|
Pneumonia
|
NIAID
|
5R01AI048052-07
|
|
The molecular mechanism of Legionella type IV secretion
|
VOGEL, JOSEPH
|
WASHINGTON UNIVERSITY
|
MO
|
$325,772
|
|
Pneumonia
|
NHLBI
|
1R01HL088989-01A1
|
|
Role of B cells in host defense against Pneumocystis
|
GARVY, BETH
|
UNIVERSITY OF KENTUCKY
|
KY
|
$366,250
|
|
Pneumonia
|
NIAID
|
5R01AI023362-23
|
|
Genetic Analysis of Mycoplasma Pneumoniae Cell Adherence
|
KRAUSE, DUNCAN
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$273,841
|
|
Pneumonia
|
NIDCD
|
5R01DC004562-10
|
|
Up-regulation of Mucin Gene Transcription-Otitis Media
|
LI, JIAN-DONG
|
UNIVERSITY OF ROCHESTER
|
NY
|
$321,185
|
|
Pneumonia
|
NIDCD
|
5R01DC006917-05
|
|
Otitis media-associated pneumococcal genes
|
ZHANG, JING-REN
|
ALBANY MEDICAL COLLEGE
|
NY
|
$332,697
|
|
Pneumonia
|
NIAID
|
7R01AI059799-04
|
|
Human T-cell Epitopes in SARS
|
BUCHMEIER, MICHAEL
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$535,318
|
|
Pneumonia
|
NIAID
|
5R01AI068112-03
|
|
Live Attenuated Recombinant Bacterial Delivery of Polysaccharide Vaccine Antigens
|
GOLDBERG, JOANNA
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$358,958
|
|
Pneumonia
|
NHLBI
|
7R01HL079392-04
|
|
Regulation and function of STAT3 during pneumonia
|
MIZGERD, JOSEPH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$385,198
|
|
Pneumonia
|
NHLBI
|
5R01HL081151-04
|
|
Regulation of pulmonary inflammation
|
HENSON, PETER
|
NATIONAL JEWISH HEALTH
|
CO
|
$369,790
|
|
Pneumonia
|
NIAID
|
5F32AI074193-02
|
|
The role of ubiquitination in Legionella pneumophila infection and disease.
|
ENSMINGER, ALEXANDER
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$49,646
|
|
Pneumonia
|
NIAID
|
5R01AI061601-06
|
|
STUDIES OF A SARS-CORONAVIRUS RECEPTOR
|
FARZAN, MICHAEL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$468,555
|
|
Pneumonia
|
NHLBI
|
1R01HL091958-01
|
|
Neutrophil Accumulation in Bacterial Pneumonia
|
JEYASEELAN, SAMITHAMBY
|
LOUISIANA STATE UNIVERSITY
|
LA
|
$354,532
|
|
Pneumonia
|
NHLBI
|
7R01HL068153-06
|
|
NF-kappaB and Innate Immunity in the Lungs
|
MIZGERD, JOSEPH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$406,250
|
|
Pneumonia
|
NIAID
|
5R01AI067995-03
|
|
Role of Innate Immunity in Pathogenesis of Chlamydia Pneumonia Infection
|
ARDITI, MOSHE
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$401,495
|
|
Pneumonia
|
NIAAA
|
5K08AA015163-05
|
|
Alcohol, Pulmonary Cytokines, and Host Defense
|
HAPPEL, KYLE
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$179,353
|
|
Pneumonia
|
NIAID
|
1R03AI078358-01
|
|
CMV Replication During Primary Infection in Lung Transplant Recipients
|
MCDYER, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$82,000
|
|
Pneumonia
|
NHLBI
|
5R01HL083482-04
|
|
Pathogenesis of HIV-Related Emphysema: T Cells, smoking*
|
BECK, JAMES
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$325,585
|
|
Pneumonia
|
NHLBI
|
5R01HL083462-04
|
|
Pneumocystis and COPD in a Simian Model of AIDS
|
NORRIS, KAREN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$370,197
|
|
Pneumonia
|
NHLBI
|
5R01HL083461-05
|
|
Pneumocystis in Pathogenesis of HIV-associated Emphysema
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,257
|
|
Pneumonia
|
NIAID
|
1K08AI077795-01
|
|
CD1d-restricted NKT cells in microbial infection
|
BRIGL, MANFRED
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$136,350
|
|
Pneumonia
|
NIAID
|
5R01AI048935-08
|
|
Mechanisms of Capsular Diversity in Streptococcus Pneumoniae
|
LIPSITCH, MARC
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$630,189
|
|
Pneumonia
|
NIAID
|
5U01AI066581-04
|
|
Real-Time PCR Assays for Direct Detection of Sepsis and CAP Pathogens
|
KEIM, PAUL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
AZ
|
$607,974
|
|
Pneumonia
|
NIAID
|
5R01AI072487-02
|
|
Type IV Secretion Systems in Legionella pneumophila
|
STEINMAN, HOWARD
|
YESHIVA UNIVERSITY
|
NY
|
$366,404
|
|
Pneumonia
|
NIAID
|
5R01AI071386-03
|
|
Infection, Inflammation and Preeclampsia
|
HAGGERTY, CATHERINE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$588,364
|
|
Pneumonia
|
NIAID
|
1R01AI075194-01A1
|
|
Streptococcus pneumoniae genetic competence and pathogenesis
|
SEBERT, MICHAEL
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$411,250
|
|
Pneumonia
|
NHLBI
|
2R01HL068864-05A2
|
|
Regulation of inflammation by pulmonary collectins
|
HENSON, PETER
|
NATIONAL JEWISH HEALTH
|
CO
|
$390,000
|
|
Pneumonia
|
NIAID
|
2R01AI055042-06
|
|
Regulation of Pseudomonas aeruginosa type III secretion
|
YAHR, TIMOTHY
|
UNIVERSITY OF IOWA
|
IA
|
$300,000
|
|
Pneumonia
|
NHLBI
|
2U54HL070590-06
|
0003
|
Pathogenesis & molecular epidemiology of Pneumococcal infection in Sickle Cell
|
TUOMANEN, ELAINE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$305,340
|
|
Pneumonia
|
NIAID
|
5F32AI069686-03
|
|
Identification of Legionella translocated effectors
|
HEIDTMAN, MATT
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$48,796
|
|
Pneumonia
|
NIAID
|
1R01AI072414-01A2
|
|
THE HUMAN ANTIBODY RESPONSE TO METAPNEUMOVIRUS: PROPHYLAXIS AND VACCINE DESIGN
|
BURTON, DENNIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$521,546
|
|
Pneumonia
|
NIAID
|
1R01AI074903-01A1
|
|
Respiratory Syncytial Virus Polymerase Protein and Promoter Interactions
|
FEARNS, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$365,625
|
|
Pneumonia
|
NIGMS
|
5R01GM069438-05
|
|
C5a in defense against murine Gram-negative pneumonia
|
YOUNGER, JOHN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$227,898
|
|
Pneumonia
|
NIAID
|
5R41AI072866-02
|
|
Human Monoclonal Antibody To Treat P. aeruginosa Infections in Cystic Fibrosis
|
PATZER, ERIC
|
ARIDIS PHARMACEUTICALS, LLC
|
CA
|
$243,632
|
|
Pneumonia
|
NIDCR
|
5R21DE017706-02
|
|
Oral Chlorhexidine effect on ICU mortality and ventilator-associated pneumonia
|
BINKLEY, CATHERINE
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$148,215
|
|
Pneumonia
|
NIAID
|
5R21AI072126-02
|
|
Chlamydia pneumoniae-Specific Inclusion Membrane Proteins
|
FIELDS, KENNETH
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$187,616
|
|
Pneumonia
|
NHLBI
|
5R01HL083470-04
|
|
STUDIES OF LUNG DISEASES OF HIV TRANSGENIC MICE
|
JOLICOEUR, PAUL
|
CLINICAL RESEARCH INSTITUTE OF MONTREAL
|
CANADA
|
$281,609
|
|
Pneumonia
|
NHLBI
|
5R01HL064520-09
|
|
Models of P. carinii infections SP-A and SP-D null mice
|
BEERS, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$364,562
|
|
Pneumonia
|
NIGMS
|
5F31GM082090-02
|
|
Defining PcsB: Essential Murein Biosynthesis Protein in Pathogenic Pneumococci
|
BARENDT, SKYE
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$38,476
|
|
Pneumonia
|
NHLBI
|
5K08HL089189-02
|
|
Role of Lipocalin 2 in host defense against Klebsiella pneumoniae infection
|
CHAN, YVONNE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$124,929
|
|
Pneumonia
|
NHLBI
|
5K08HL081537-02
|
|
IL-23: Actions and Regulation in Pseudomonas aeruginosa Pulmonary Infection
|
DUBIN, PATRICIA
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$107,619
|
|
Pneumonia
|
NIAID
|
1R21AI073928-01A2
|
|
Development of a plant-derived virus-like particle vaccine against SARS-CoV
|
HUANG, ZHONG
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$187,701
|
|
Pneumonia
|
NIAID
|
1R03AI073326-01A1
|
|
An in vivo Gene Deletion System for Analyzing Temporal Requirement of the Dot/Icm
|
LUO, ZHAO-QING
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
IN
|
$72,783
|
|
Pneumonia
|
NIDCR
|
5U01DE017788-03
|
|
Microsensor Arrays for Saliva Diagnostics
|
WALT, DAVID
|
TUFTS UNIVERSITY MEDFORD
|
MA
|
$1
|
|
Pneumonia
|
NIAID
|
2K24AI052788-06A1
|
|
Clinical Research and Mentoring in Epidemiology of Bacterial Diseases
|
HARRISON, LEE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$166,629
|
|
Pneumonia
|
NIAID
|
1R01AI075297-01A1
|
|
SARS-CoV Pathogenic Mechanisms in Senescent Mice
|
BARIC, RALPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$496,151
|
|
Pneumonia
|
NIAID
|
5R43AI072921-02
|
|
Inhibition of Ebola Virus Infection with Cathepsin L Inhibitors
|
PEET, NORTON
|
MICROBIOTIX, INC
|
MA
|
$300,000
|
|
Pneumonia
|
NIAID
|
5R43AI072783-02
|
|
Diagnostic protein array for respiratory infections
|
CHANDLER, DARRELL
|
AKONNI BIOSYSTEMS, INC.
|
MD
|
$296,316
|
|
Pneumonia
|
NICHD
|
1U01HD058322-01
|
|
Improving Quality of Care for the Treatment of Childhood Pneumonia
|
HIBBERD, PATRICIA
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$728,994
|
|
Pneumonia
|
NIAID
|
1R13AI078541-01
|
|
17th Congress of the International Organization for Mycoplasmology
|
KRAUSE, DUNCAN
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$10,000
|
|
Pneumonia
|
NIDA
|
5K02DA015349-07
|
|
Role of Mu Opioid Receptor in Immune Function
|
ROY, SABITA
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$126,749
|
|
Pneumonia
|
NIAID
|
5R01AI072493-02
|
|
Analysis of SARS Coronavirus-Host Cell Interactions
|
MAKINO, SHINJI
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$296,262
|
|
Pneumonia
|
NIAID
|
5U01AI066584-04
|
|
Diagnostics for Sepsis and Community-Acquired Pneumonia
|
WEISBURG, WILLIAM
|
NANOGEN, INC.
|
CA
|
$472,430
|
|
Pneumonia
|
NIAID
|
5R01AI066304-03
|
|
Post-PCV pneumococcal population genetics and resistance
|
FINKELSTEIN, JONATHAN
|
HARVARD PILGRIM HEALTH CARE, INC.
|
MA
|
$647,359
|
|
Pneumonia
|
NIAID
|
1R43AI078567-01
|
|
Detection of Antibiotic Resistance Genes in Bacterial Agents of Hospital-Acquired
|
LEVIN, ANDREW
|
IMMUNETICS, INC.
|
MA
|
$299,999
|
|
Pneumonia
|
NIDDK
|
2R44DK075198-02
|
|
Rapid Diagnostic Testing of Urinary Tract Infections
|
RIEDER, RONALD
|
BIOSENSE TECHNOLOGIES, INC.
|
MA
|
$405,129
|
|
Pneumonia
|
NIGMS
|
5R01GM074756-04
|
|
Foldamers: Novel Ligands for Diverse Protein Surfaces
|
SCHEPARTZ, ALANNA
|
YALE UNIVERSITY
|
CT
|
$417,716
|
|
Pneumonia
|
NIAID
|
5R01AI070829-02
|
|
Molecular basis of mef-mediated antibiotic resistance in Streptococcus pneumoniae
|
STEPHENS, DAVID
|
EMORY UNIVERSITY
|
GA
|
$372,633
|
|
Pneumonia
|
NIAID
|
5R21AI074783-02
|
|
HMPV Fusion protein-host cell interactions
|
DUTCH, REBECCA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$215,575
|
|
Pneumonia
|
NIAID
|
1R13AI078718-01
|
|
10TH & 11TH INTERNATIONAL WORKSHOPS ON OPPORTUNISTIC PROTISTS (IWOP-10; IWOP-11)
|
KANESHIRO, EDNA
|
UNIVERSITY OF CINCINNATI
|
OH
|
$20,000
|
|
Pneumonia
|
NIA
|
5R01AG015978-08
|
|
Elderly Immune Response to Pneumococcal Polysaccharide
|
WESTERINK, M.A.
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$287,411
|
|
Pneumonia
|
NHLBI
|
1F32HL092743-01
|
|
Role of alveolar macrophage NF-kappa B RelA subunit during bacterial pneumonia
|
MCNAMEE, LYNNELLE
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$46,826
|
|
Pneumonia
|
NIEHS
|
5F30ES015413-03
|
|
Determinants of antibody-based host resistance against Pneumocystis carinii
|
RAPAKA, REKHA
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$23,522
|
|
Pneumonia
|
NIAID
|
5U01AI066590-04
|
|
Microfluidic PCR Platform to Detect Microbial DNA
|
MITCHELL, THOMAS
|
DUKE UNIVERSITY
|
NC
|
$617,154
|
|
Pneumonia
|
NIGMS
|
5K08GM078610-03
|
|
Gram-Negative Pneumonia and Lipopolysaccharide Binding Protein
|
HEMMILA, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$128,520
|
|
Pneumonia
|
NHLBI
|
5R01HL062052-11
|
|
CD8 T-Cells and Host Defense Against P. Carinii
|
KOLLS, JAY
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$315,288
|
|
Pneumonia
|
NIA
|
1F30AG031035-01A1
|
|
Influenza and Secondary Bacterial Pneumonia
|
CHAKRAVARTHY, KRISHNAN
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$39,085
|
|
Pneumonia
|
NHLBI
|
5R01HL055934-14
|
|
Control of the Pneumocystis carinii Life Cycle
|
LIMPER, ANDREW
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$356,423
|
|
Pneumonia
|
NIGMS
|
5R01GM072808-04
|
|
Mechanisms of Intestinal Apoptosis in Sepsis and Shock
|
COOPERSMITH, CRAIG
|
WASHINGTON UNIVERSITY
|
MO
|
$249,695
|
|
Pneumonia
|
NHLBI
|
5K24HL087713-03
|
|
Patient-Oriented Research and Mentoring in Pneumocystis
|
HUANG, LAURENCE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$169,936
|
|
Pneumonia
|
NHLBI
|
5K08HL080701-04
|
|
Lung Alloimmunity after Bone Marrow Transplantation
|
WOOD, KAREN
|
OHIO STATE UNIVERSITY
|
OH
|
$130,518
|
|
Pneumonia
|
NIAID
|
5U01AI061318-05
|
|
Human Antibodies and Targeted Vaccines Against SARS-CoV
|
MARASCO, WAYNE
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$709,379
|
|
Pneumonia
|
NHLBI
|
5K08HL083092-03
|
|
Pseudomonas invasion and the role of caveolin-2
|
ZAAS, DAVID
|
DUKE UNIVERSITY
|
NC
|
$118,750
|
|
Pneumonia
|
NHLBI
|
5K08HL083103-02
|
|
Adenovirus modulation of pulmonary inflammation
|
WEINBERG, JASON
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$132,083
|
|
Pneumonia
|
NHLBI
|
5K08HL077344-04
|
|
Hypoxic inflammation, pulmonary hypertension, and HO-1
|
VITALI, SALLY
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$128,580
|
|
Pneumonia
|
NIAID
|
5U01AI066569-04
|
|
Plasma Protein Biomarker-Based Diagnostics Of Outcome In Sepsis and CAP
|
KINGSMORE, STEPHEN
|
NATIONAL CENTER FOR GENOME RESOURCES
|
NM
|
$491,218
|
|
Pneumonia
|
NIA
|
5K23AG028954-02
|
|
Pharmacepidemiology in the elderly: medications pneumonia risk and confounding
|
DUBLIN, SASCHA
|
CENTER FOR HEALTH STUDIES
|
WA
|
$146,271
|
|
Pneumonia
|
NIAID
|
5U01AI070369-03
|
|
Therapeutics targeting cathepsin-activated viral entry
|
BATES, PAUL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$473,753
|
|
Pneumonia
|
NHLBI
|
5K23HL081491-04
|
|
Probiotic Prophylaxis of Ventilator-Associated Pneumonia
|
MORROW, LEE
|
CREIGHTON UNIVERSITY
|
NE
|
$129,600
|
|
Pneumonia
|
NIGMS
|
5K08GM081459-02
|
|
Bacterial Pneumonia and Neutrophil Recruitment During Acute Renal Failure
|
SINGBARTL, KAI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$120,795
|
|
Pneumonia
|
NIAID
|
1R01AI076104-01A2
|
|
Biofilm Formation by Pneumocystis
|
CUSHION, MELANIE
|
UNIVERSITY OF CINCINNATI
|
OH
|
$365,754
|
|
Pneumonia
|
NIAID
|
5R21AI072201-02
|
|
Inflammatory Response and SARS Pathogenesis: An in vitro Model
|
TSENG, CHIEN-TE
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$222,197
|
|
Pneumonia
|
NIAID
|
5R21AI071109-02
|
|
Determining SARS-CoV host gene requirements by mutagenesis and RNA interface
|
HOGAN, ROBERT
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$180,872
|
|
Pneumonia
|
NIAID
|
5R21AI073816-02
|
|
Regulation of Fatty Acid Biosynthesis and Degradation in Pseudomonas aeruginosa
|
HOANG, TUNG
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$203,656
|
|
Pneumonia
|
NHLBI
|
5R01HL090316-02
|
|
Longtitudinal Studies of HIV-Associated Bacterial Pneumonia
|
ROM, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$803,016
|
|
Pneumonia
|
NHLBI
|
5R01HL090335-02
|
|
International HIV-associated Opportunistic Pneumonias (IHOP) Study
|
HUANG, LAURENCE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$740,203
|
|
Pneumonia
|
NHLBI
|
7R01HL067939-07
|
|
Improving Ventilator Management and Preventing Injury to Patients with ARF
|
RUBENFELD, GORDON
|
SUNNYBROOK & WOMEN'S COLL HLTH SCIS CTR
|
CANADA
|
$492,337
|
|
Pneumonia
|
FIC
|
1R01TW008126-01
|
|
Burden of RSV and Influenza Virus in Children in Pakistan
|
ALI, SYED
|
AGA KHAN UNIVERSITY
|
PAKIST
|
$50,760
|
|
Pneumonia
|
NIAID
|
5R21AI072312-02
|
|
Assembly and release of the SARS coronavirus
|
MACHAMER, CAROLYN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$201,105
|
|
Pneumonia
|
NIDA
|
5R03DA023353-02
|
|
Opioid abuse and host defense against streptococcus pneumoniae lung infection
|
WANG, JINGHUA
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$73,255
|
|
Pneumonia
|
NIA
|
5R21AG029313-02
|
|
Age-associated inflammation increases susceptibility to pneumococcal infection
|
ORIHUELA, CARLOS
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$152,023
|
|
Pneumonia
|
NINR
|
5R01NR010828-02
|
|
Impact of statins and ACE inhibitors on outcomes for pneumonia and sepsis
|
MORTENSEN, ERIC
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$311,563
|
|
Pneumonia
|
NHLBI
|
1K99HL092956-01
|
|
Lung-Liver Axis During Pneumonia
|
QUINTON, LEE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$102,014
|
|
Pneumonia
|
NIAID
|
1R21AI079345-01
|
|
Virulence Gene Discovery in Outbreak-Associated Pneumococci
|
ROBINSON, D
|
NEW YORK MEDICAL COLLEGE
|
NY
|
$158,917
|
|
Pneumonia
|
NIAID
|
1R01AI079330-01
|
|
Targeting MDR hetero-resistant Gram-negatives: PK/PD for rational combinations
|
NATION, ROGER
|
MONASH UNIVERSITY
|
AUSTRA
|
$447,872
|
|
Pneumonia
|
NHLBI
|
2R01HL062150-16
|
|
Pneumocystis carinii: Macrophage and Epithelial Activation
|
LIMPER, ANDREW
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$377,750
|
|
Pneumonia
|
NIA
|
5F30AG030298-02
|
|
The Contribution of Chronic Inflammation to Pulmonary Adenocarcinoma
|
DOUGAN, MICHAEL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$45,972
|
|
Pneumonia
|
NIAID
|
1R01AI079578-01
|
|
Resistance Suppression for P. Aeruginosa using Novel Combination Therapy Modeling
|
DRUSANO, GEORGE
|
ORDWAY RESEARCH INSTITUTE, INC.
|
NY
|
$787,916
|
|
Pneumonia
|
NIAID
|
2R01AI049194-05A1
|
|
Mycoplasma pneumoniae Gliding Motility
|
KRAUSE, DUNCAN
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$351,000
|
|
Pneumonia
|
NIAID
|
2R01AI043060-10A2
|
|
Chlamydia Pneumoniae Antigens of Bilogogical Significance
|
CAMPBELL, LEE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$390,000
|
|
Pneumonia
|
NIAID
|
1R01AI076256-01A1
|
|
Alternative Strategies for Adult Pneumococcal Vaccination
|
SMITH, KENNETH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$227,250
|
|
Pneumonia
|
NHLBI
|
1R01HL087001-01A2
|
|
Pathophysiology of PPARgamma in the lung
|
DU, HONG
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$375,000
|
|
Pneumonia
|
NIAID
|
2R01AI028457-16A1
|
|
Genetics and virulence of pneumococcal capsular types
|
YOTHER, JANET
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$326,250
|
|
Pneumonia
|
NIAID
|
2R01AI021548-24A1
|
|
PspA: A Potential Pneumococcal Vaccine Component
|
BRILES, DAVID
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$506,758
|
|
Pneumonia
|
NHLBI
|
2R01HL071233-07A1
|
|
Structure-Function Relationships of C-Reactive Protein
|
AGRAWAL, ALOK
|
EAST TENNESSEE STATE UNIVERSITY
|
TN
|
$311,100
|
|
Pneumonia
|
NIAID
|
1R01AI075039-01A2
|
|
Intracellular sensing of flagellin and innate immunity to Legionella pneumophila
|
VANCE, RUSSELL
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$338,666
|
|
Pneumonia
|
NHLBI
|
1R01HL086825-01A2
|
|
Epithelial Dysfunction in Early IPF
|
BLACKWELL, TIMOTHY
|
VANDERBILT UNIVERSITY
|
TN
|
$651,760
|
|
Pneumonia
|
NIGMS
|
1K23GM083215-01A1
|
|
Predicting Risk of Pneumonia in the General Population
|
YENDE, SACHIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$119,249
|
|
Pneumonia
|
NIAID
|
1R21AI076781-01A1
|
|
RSV Vaccine Development Based on HPV Virus-Like Particles
|
MURATA, YOSHIHIKO
|
UNIVERSITY OF ROCHESTER
|
NY
|
$227,490
|
|
Pneumonia
|
NIAID
|
1R21AI078189-01A1
|
|
Pneumococcal transmission in urban environments
|
METLAY, JOSHUA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$293,500
|
|
Pneumonia
|
NHLBI
|
2R01HL070946-05A2
|
|
Group V Phospholipase A2 and Pulmonary Inflammation
|
ARM, JONATHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$371,250
|
|
Pneumonia
|
NIAID
|
1R03AI074894-01A2
|
|
Etiology, Epidemiology, and Clinical Outcomes of Health Care Associated Pneumonia
|
MADARAS-KELLY, KARL
|
IDAHO STATE UNIVERSITY
|
ID
|
$61,996
|
|
Pneumonia
|
NIAID
|
1R21AI073467-01A1
|
|
Impact of Fluoroquinolone resistance on Pseudomonas virulence and patient outcome
|
WONG-BERINGER, ANNIE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$203,750
|
|
Pneumonia
|
NIAAA
|
5P60AA009803-15
|
0002
|
Alcohol, SIV infection, and Host Defense
|
NELSON, STEVE
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$217,292
|
|
Pneumonia
|
NIAAA
|
5P60AA009803-15
|
0013
|
Ethanol & Infection on Mitochondrial Death Signaling
|
KANTROW, STEPHEN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$178,432
|
|
Pneumonia
|
NIAAA
|
5P60AA009803-15
|
0015
|
Alcohol, IL17, and Klebsiella Pneumonia
|
SHELLITO, JUDD
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$423,991
|
|
Pneumonia
|
NIAID
|
7K08AI071090-02
|
|
Mechanisms of intraspecies Competition in Streptococcus pneumoniae.
|
DAWID, SUZANNE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$75,798
|
|
Pneumonia
|
NHLBI
|
1F32HL094000-01
|
|
Role of Stromelysin-2 in Mediating P. aeruginosa-induced Lung Inflammation
|
LIN, MICHELLE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$44,846
|
|
Pneumonia
|
OD
|
1U01ES017219-01
|
|
Prevention of Inflammatory Lung Injury After Chlorine Exposure
|
GUNN, MICHAEL
|
DUKE UNIVERSITY
|
NC
|
$401,764
|
|
Pneumonia
|
NIAID
|
1F32AI074271-01A2
|
|
Subcellular Protein Localization in Pseudomonas aeruginosa Virulence
|
COWLES, KIMBERLY
|
PRINCETON UNIVERSITY
|
NJ
|
$46,826
|
|
Pneumonia
|
NHLBI
|
1F32HL094004-01
|
|
Innate immunity to acute P. aeruginosa Pneumonia
|
MORRIS, AMY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$58,886
|
|
Pneumonia
|
NHLBI
|
1R01HL092797-01A1
|
|
P. carinii Pneumonia Lung Damage: CD8-driven Cellular and Molecular Events
|
GIGLIOTTI, FRANCIS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$383,920
|
|
Pneumonia
|
NIAID
|
1K24AI080298-01A1
|
|
HIV activation in secondary pulmonary infection
|
WEIDEN, MICHAEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$139,368
|
|
Pneumonia
|
NHLBI
|
1F32HL094232-01
|
|
Bacterial Communities in the HIV-Infected Lung
|
FEI, MATTHEW
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$65,342
|
|
Pneumonia
|
RMAP
|
1R21NS063854-01
|
|
Yeast Based Assays for Chemical Screens Against SARS-CoV Targets
|
ENGEL, DANIEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$157,259
|
|
Pneumonia
|
NIAID
|
5P01AI059443-04
|
0001
|
Rewiring SARS-CoV Genome Organization and Pathogenesis
|
BARIC, RALPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$257,344
|
|
Pneumonia
|
NIAID
|
5P01AI059443-04
|
0002
|
SARS Replicase Proteins in Pathogenesis and Replication
|
DENISON, MARK
|
VANDERBILT UNIVERSITY
|
TN
|
$410,455
|
|
Pneumonia
|
NIAID
|
5P01AI059443-04
|
0003
|
Anti-IFN Activity of SARS Virus and SARS Vaccines
|
PALESE, PETER
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$395,887
|
|
Pneumonia
|
NIAID
|
5P01AI059443-04
|
0004
|
Alphavirus Vectored Vaccines for the SARS Coronavirus
|
JOHNSTON, ROBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$287,577
|
|
Pneumonia
|
NIAID
|
5P01AI059443-04
|
9001
|
Core-- Animal Models
|
HEISE, MARK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$306,973
|
|
Pneumonia
|
NIAID
|
5P01AI059443-04
|
9002
|
Core--SARS Coronavirus Clone and Reagent
|
BARIC, RALPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$196,600
|
|
Pneumonia
|
NHLBI
|
5P01HL076100-05
|
0001
|
CXCR3 Chemokines, Lymphocytes Recruitment, and P. Carinii
|
SHELLITO, JUDD
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$321,862
|
|
Pneumonia
|
NHLBI
|
5P01HL076100-05
|
0002
|
CD4-Independent Vaccinations for Pulmonary Infections
|
KOLLS, JAY
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$367,184
|
|
Pneumonia
|
NINR
|
2R01NR007652-06A1
|
|
Oral Care Intervention in Mechanically Ventilated Adults
|
MUNRO, CINDY
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$445,895
|
|
Pneumonia
|
NIAID
|
1RC1AI081244-01
|
|
Combined Target Therapy for the Pulmonary Syndrome
|
WILLIAMS, JACQUELINE
|
UNIVERSITY OF ROCHESTER
|
NY
|
$50,311
|
|
Pneumonia
|
OD
|
1RC1AI081244-01
|
|
Combined Target Therapy for the Pulmonary Syndrome
|
WILLIAMS, JACQUELINE
|
UNIVERSITY OF ROCHESTER
|
NY
|
$949,688
|
|
Pneumonia
|
NHLBI
|
5P01HL073907-05
|
0004
|
Mechanism of Mycoplasma-Induced Mast Cell Il-4 Synthesis
|
ATKINSON, THOMAS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$458,144
|
|
Pneumonia
|
NHLBI
|
5P01HL073907-05
|
9001
|
CORE--Histopathology and Microbiology
|
CHU, HONG
|
NATIONAL JEWISH HEALTH
|
CO
|
$589,522
|
|
Pneumonia
|
NIAID
|
5P01AI060915-04
|
0001
|
Identifying Therapeutic Targets in SARS-CoV Replicase
|
BAKER, SUSAN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$425,409
|
|
Pneumonia
|
NIAID
|
5P01AI060915-04
|
0002
|
Mechanistic & Crystallographic Studies of SARS Proteases
|
MESECAR, ANDREW
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$260,103
|
|
Pneumonia
|
NIAID
|
5P01AI060915-04
|
9001
|
Protein Expression and Purification
|
MESECAR, ANDREW
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$172,422
|
|
Pneumonia
|
NHLBI
|
1R03HL095370-01
|
|
Defining the Role of Pneumocystis in COPD Pathogenesis
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$75,750
|
|
Pneumonia
|
NHLBI
|
1R01HL095393-01
|
|
Genomic Signatures for Idiopathic Interstitial Pneumonia
|
SCHWARTZ, DAVID
|
NATIONAL JEWISH HEALTH
|
CO
|
$786,809
|
|
Pneumonia
|
RMAP
|
1R03MH085680-01
|
|
High Throughput Screen for Inhibitors of Influenza NS1 Protein Function
|
ENGEL, DANIEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$24,999
|
|
Pneumonia
|
NIAID
|
5U54AI065357-04
|
0025
|
Immunopathogenesis of Coxiella pneumonia
|
HARMSEN, ALLEN
|
MONTANA STATE UNIVERSITY (BOZEMAN)
|
MT
|
$320,745
|
|
Pneumonia
|
NIBIB
|
5U54EB007959-02
|
9001
|
Core 1 - Rapid Multipathogen Detection For POCT and Natioal Disaster Readiness
|
KOST, GERALD
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$1,118,038
|
|
Pneumonia
|
NIAID
|
1R56AI073663-01A2
|
|
CD86 Signaling in B Cells
|
SANDERS, VIRGINIA
|
OHIO STATE UNIVERSITY
|
OH
|
$375,000
|
|
